Last reviewed · How we verify
DWC202201
At a glance
| Generic name | DWC202201 |
|---|
| Sponsor | Daewoong Pharmaceutical Co. LTD. |
|---|
| Modality | Small molecule |
|---|
| Phase | Phase 1 |
|---|
Approved indications
No approved indications tracked.
Common side effects
No common side effects on file.